Sign inCreate account

Report workspace tools

NCT03871491COMPLETEDanonymous

Prevention of Maternal and Neonatal Death/Infections With a Single Oral Dose of Azithromycin in Women in Labor (in Low- and Middle-income Countries): a Randomized Controlled Trial

Sponsor

Source record

NICHD Global Network for Women's and Children's Health

Phase

Source record

PHASE3

Modality

AI-normalized

RNA therapy

Target

AI-normalized

Maternal and neonatal infections

Indication / condition

AI-normalized

Maternal Death

Intervention

Source record

Azithromycin, Placebo

Source & freshness

Source record

NCT ID

NCT03871491

Original source

ClinicalTrials.gov

Source last updated

Oct 24, 2024

Ingested at

May 23, 2026

Internal sync

Jun 05, 2026

Model version

trialsignal-ai-v1

Normalized confidence

88%

Validation status

validated

Open original registry record
View original source fields

NCT ID

NCT03871491

Title

Prevention of Maternal and Neonatal Death/Infections With a Single Oral Dose of Azithromycin in Women in Labor (in Low- and Middle-income Countries): a Randomized Controlled Trial

Sponsor

NICHD Global Network for Women's and Children's Health

Status

COMPLETED

Phase

PHASE3

Condition raw

Maternal Death

Condition normalized

Maternal Death

Modality raw

Maternal Death

Modality normalized

RNA therapy

Target raw

Maternal and neonatal infections

Target normalized

Maternal and neonatal infections

Interventions

Azithromycin, Placebo

Public preview

Source record

The A-PLUS trial investigates the efficacy of a single oral dose of azithromycin in reducing maternal and neonatal deaths and infections during labor in low- and middle-income countries. Conducted by the NICHD Global Network, it aims to address significant public health issues related to maternal and neonatal mortality.

AI-generated analysis supports research triage only. Verify source records, publications, sponsor disclosures and IP databases before making diligence decisions. Model: trialsignal-ai-v1.

Report access

Create an account to unlock this report

Choose the access model that matches the job: one urgent report, reusable credits for project work, or unlimited monthly access with AI and folders.

Full protocol, outcomes, eligibility, contacts and results sections
Patent/IP landscape with verified records when available
Board-ready PDF export with source provenance
Save to folders and synthesize multiple assets in premium workspace
Create account
Sign in

Create a free account first, then unlock a single report, buy credits or subscribe.

TrialSignal

Clinical trial intelligence report

Prevention of Maternal and Neonatal Death/Infections With a Single Oral Dose of Azithromycin in Women in Labor (in Low- and Middle-income Countries): a Randomized Controlled Trial

Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.

Generated

Jun 13, 2026

NCT ID

NCT03871491

Status

COMPLETED

Phase

PHASE3

Sponsor

NICHD Global Network for Women's and Children's Health

Executive brief

Investment-Ready Snapshot

The A-PLUS trial investigates the efficacy of a single oral dose of azithromycin in reducing maternal and neonatal deaths and infections during labor in low- and middle-income countries. Conducted by the NICHD Global Network, it aims to address significant public health issues related to maternal and neonatal mortality.

Source & freshness

Provenance

SourceClinicalTrials.gov
Source updatedOct 24, 2024
Internal syncJun 05, 2026
Model versiontrialsignal-ai-v1

https://clinicaltrials.gov/study/NCT03871491

Indication

Maternal Death

Modality

RNA therapy

Target

Maternal and neonatal infections

Intervention

Azithromycin, Placebo

Source record

Protocol Description

Detailed source ingestion pending.

Source record

Outcome Measures

Detailed source ingestion pending.

Source record

Eligibility

Detailed source ingestion pending.

AI analysis

Known Results And Readout Context

Detailed source ingestion pending.

IP intelligence

Patent And IP Landscape

Detailed source ingestion pending.

Source record

Contacts

Detailed source ingestion pending.